Sepsis & infection

Plasma Metabolomics Reveals Distinct Biological and Diagnostic Signatures for Melioidosis

Am J Respir Crit Care MedPublished Prospective cohort study

Authors' conclusion

Melioidosis induces a distinct metabolomic state that can be examined to distinguish underlying pathophysiological mechanisms associated with death. A 12-metabolite signature accurately differentiates melioidosis from other infections and may have diagnostic applications.

Study context

Population
Patients hospitalized with infection in rural Thailand
Participants
175 vs 75
Exposure
Melioidosis vs nonmelioidosis infections; nonsurvivors vs survivors
  • Melioidosisn = 175
  • Nonmelioidosis infectionsn = 75reference
Outcome
Metabolomic profile and diagnostic classifier for melioidosis
Methodological detailsplasma metabolomics analysis, validation set
  • Plasma metabolomics analysis
  • Validation set

Main finding

As reported in the abstract

12-metabolite classifier distinguishing melioidosis from other infections, AUC in a second validation set

0.87

Observational data: associations, not effects.

Further findings

Significantly disturbed metabolome in nonsurvivors vs survivors, with increased leucine, isoleucine and valine metabolism and elevated circulating free fatty acids and acylcarnitines
A limited eight-metabolite panel showed promise as an early prognosticator of mortality in melioidosis
  • Nonsurvivors n = 94; survivors n = 81

Original publication

Plasma Metabolomics Reveals Distinct Biological and Diagnostic Signatures for Melioidosis. Am J Respir Crit Care Med. Published 1 February 2024. doi:10.1164/rccm.202207-1349oc

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.